Web-based education for Alzheimer Disease

Phase-Based Progress Estimates
Alzheimer Disease+5 More
Web-based education - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will test an online educational course for Alzheimer's disease prevention, treatment, and caregiving.

Eligible Conditions
  • Alzheimer Disease
  • Alzheimer's Disease
  • Memory Losses
  • Patient Education as Topic

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Alzheimer Disease

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: 12 months

12 months
Behavioral Assessments
Knowledge of AD Preventative behaviors
Participant Satisfaction
Willingness to Engage in AD Preventative behaviors

Trial Safety

Safety Progress

1 of 3

Other trials for Alzheimer Disease

Trial Design

2 Treatment Groups

1 of 2
Time-neutral control
1 of 2
Experimental Treatment
Non-Treatment Group

10000 Total Participants · 2 Treatment Groups

Primary Treatment: Web-based education · Has Placebo Group · N/A

Experimental Group · 1 Intervention: Web-based education · Intervention Types: Behavioral
Time-neutral control
ShamComparator Group · 1 Intervention: Web-based education · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
983 Previous Clinical Trials
1,328,052 Total Patients Enrolled
8 Trials studying Alzheimer Disease
1,782 Patients Enrolled for Alzheimer Disease
Richard Isaacson, MDPrincipal InvestigatorWeill Medical College of Cornell University

Eligibility Criteria

Age Any Age · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: October 26th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.